Search research articles
Contact Us
Filters
Showing results (81-90 of 126) with videos related to
Page
of 13
Sort By:
JACC. Cardiovascular Interventions
|
October 24, 2009
Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease
Ajay J Kirtane, Rikesh Patel, Charles O'Shaughnessy, et al.
Frontiers in Cardiovascular Medicine
|
January 26, 2026
Lipoprotein(a): the neglected risk factor in cardiovascular health
Allister Irvine, Joanne Watt, Mary Jo Kurth, et al.
Scientific Reports
|
November 20, 2019
Stratifying risk of acute kidney injury in pre and post cardiac surgery patients using a novel biomarker-based algorithm and clinical risk score
William T McBride, Mary Jo Kurth, Gavin McLean, et al.
Nature
|
October 14, 2014
Cohesin-dependent globules and heterochromatin shape 3D genome architecture in S. pombe
Takeshi Mizuguchi, Geoffrey Fudenberg, Sameet Mehta, et al.
JACC. Cardiovascular Interventions
|
September 24, 2013
First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries)
John Ormiston, Mark Webster, James Stewart, et al.
Plos One
|
October 25, 2019
Correction: Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population
Vesna Gorenjak, Dwaine R Vance, Alexandros M Petrelis, et al.
Journal of Lipid Research
|
December 4, 2012
A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C
Maria G Stathopoulou, Amélie Bonnefond, Ndeye Coumba Ndiaye, et al.
Frontiers in Nutrition
|
February 2, 2023
Analysis of reactive aldehydes in urine and plasma of type-2 diabetes mellitus patients through liquid chromatography-mass spectrometry: Reactive aldehydes as potential markers of diabetic nephropathy
Carla Harkin, Diego Cobice, Joanne Watt, et al.
Frontiers in Endocrinology
|
July 18, 2022
Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients
Carla Harkin, Diego Cobice, Simon Brockbank, et al.
Plos One
|
August 17, 2019
Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population
Vesna Gorenjak, Dwaine R Vance, Alexandros M Petrelis, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 126) with videos related to
Sort By:
Page
of 13
JACC. Cardiovascular Interventions
|
October 24, 2009
Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease
Ajay J Kirtane, Rikesh Patel, Charles O'Shaughnessy, et al.
Frontiers in Cardiovascular Medicine
|
January 26, 2026
Lipoprotein(a): the neglected risk factor in cardiovascular health
Allister Irvine, Joanne Watt, Mary Jo Kurth, et al.
Scientific Reports
|
November 20, 2019
Stratifying risk of acute kidney injury in pre and post cardiac surgery patients using a novel biomarker-based algorithm and clinical risk score
William T McBride, Mary Jo Kurth, Gavin McLean, et al.
Nature
|
October 14, 2014
Cohesin-dependent globules and heterochromatin shape 3D genome architecture in S. pombe
Takeshi Mizuguchi, Geoffrey Fudenberg, Sameet Mehta, et al.
JACC. Cardiovascular Interventions
|
September 24, 2013
First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries)
John Ormiston, Mark Webster, James Stewart, et al.
Plos One
|
October 25, 2019
Correction: Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population
Vesna Gorenjak, Dwaine R Vance, Alexandros M Petrelis, et al.
Journal of Lipid Research
|
December 4, 2012
A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C
Maria G Stathopoulou, Amélie Bonnefond, Ndeye Coumba Ndiaye, et al.
Frontiers in Nutrition
|
February 2, 2023
Analysis of reactive aldehydes in urine and plasma of type-2 diabetes mellitus patients through liquid chromatography-mass spectrometry: Reactive aldehydes as potential markers of diabetic nephropathy
Carla Harkin, Diego Cobice, Joanne Watt, et al.
Frontiers in Endocrinology
|
July 18, 2022
Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients
Carla Harkin, Diego Cobice, Simon Brockbank, et al.
Plos One
|
August 17, 2019
Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population
Vesna Gorenjak, Dwaine R Vance, Alexandros M Petrelis, et al.
Page
of 13